1.美國(guó)糖尿病協(xié)會(huì)ADA《Standards of Care in Diabetes---2024》推薦

2.世界衛(wèi)生組織WHO《Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection》推薦

3.中華醫(yī)學(xué)會(huì)肝病學(xué)分會(huì)《代謝相關(guān)（非酒精性）脂肪性肝病防治指南（2024年版）》推薦

4.歐洲肝臟研究協(xié)會(huì)(EASL)、歐洲糖尿病研究協(xié)會(huì)(EASD)、歐洲肥胖研究協(xié)會(huì)(EASO)《EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)》推薦

5.兒童MAFLD專家共識(shí) 《An international multidisciplinary consensus on pediatric metabolic dysfunction-associated fatty liver disease》推薦

6.韓國(guó)肝臟病研究學(xué)會(huì)（KASL）《KASL Clinical Practice Guidelines for Noninvasive Tests to Assess Liver Fibrosis in Chronic Liver Disease》推薦

7.美國(guó)肝臟研究學(xué)會(huì)（AASLD）《Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance》推薦

8.中華醫(yī)學(xué)會(huì)肝病學(xué)分會(huì)英文版MAFLD指南《Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024)》推薦

英國(guó)NICE2023指南推薦

美國(guó)AASLD關(guān)于NAFLD臨床評(píng)估和管理實(shí)踐指導(dǎo)推薦

美國(guó)ADA糖尿病診療標(biāo)準(zhǔn)推薦

英國(guó)BASL關(guān)于NAFLD管理質(zhì)量標(biāo)準(zhǔn)共識(shí)推薦

美國(guó)AHA非酒精性脂肪性肝病與心血管風(fēng)險(xiǎn)科學(xué)聲明推薦

AACE初級(jí)保健和內(nèi)分泌臨床環(huán)境中的NAFLD診斷與管理臨床實(shí)踐指南推薦Baveno VI共識(shí)推薦

中國(guó)原發(fā)性肝癌診療指南(2022年版)推薦

中華醫(yī)學(xué)會(huì)原發(fā)性肝癌二級(jí)預(yù)防共識(shí)推薦中華醫(yī)學(xué)會(huì)中國(guó)成人T2D合并NAFLD管理專家共識(shí)推薦EASL非侵入性檢測(cè)評(píng)估肝病嚴(yán)重程度和預(yù)后實(shí)踐指南推薦

英國(guó)NICE指南推薦FibroScan?在初級(jí)保健的應(yīng)用

韓國(guó)T2D合并NAFLD聲明推薦

ALEH非酒精性脂肪性肝病診斷和治療實(shí)踐指南推薦

APASL代謝相關(guān)脂肪性肝病專家共識(shí)推薦

APASL代謝相關(guān)脂肪性肝病臨床診療指南推薦

中國(guó)新冠后疫情時(shí)代門脈高壓全病程管理專家共識(shí)推